CMAB BioPharm
Suzhou
About CMAB BioPharm
CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company. Strictly in compliance with the quality standards of domestic and international pharmaceutical production management regulations, Suqiao Bio is committed to providing Chinese and global customers with a one-stop shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. solution.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $72.0M
- Funding stage: M&A
- Last round: Series B (Apr 2018)
- Website: cmabbio.com
- Phone: (+86) 0512 6799 5188
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/cmab-biopharm-89007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.